[PDF] Top 20 Conocimientos sobre riesgos laborales en el personal de salud del Hospital General de Macas 2016

... Treatment delay was measured in two ways: 1) the pro- portion of patients who delayed their index chemotherapy based on the presence of a significant gap between two che- motherapy cycles, and 2) the ... See full document

... the treatment of dif- ferent malignancies are known to cause significant side ...is nausea and vomiting. Poorly controlled chemotherapy-induced nausea and vomiting (CINV) can ... See full document

... of nausea and vomiting is the main goal of antiemetic treatment in cancer patients scheduled to receive ...before chemotherapy and patients should be protected for up to 24 hours after ... See full document

... )-receptor antagonists (RAs) for preventing chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy, a literature search was ... See full document

... other 5-HT 3 receptor antagonists (with the notable exception of granis- etron) is, in part, dependent on the CYP2D6 isoform ...clinical impact in certain ...may impact the efficacy of ... See full document

... NK-1 receptor antagonists for the treatment of delayed ...the 5-HT 3 receptor antagonist palonosetron) in ...delayed nausea and vomiting associated with initial and ... See full document

... Fewer chemotherapy treat- ment days, in and by itself, was associated with higher risk for CINV experience, because of the higher chemo- therapy dose used in a shorter time ...of chemotherapy and lower risk ... See full document

... Background: Chemotherapy-induced nausea and vomiting (CINV) are major adverse effects of cancer ...negative impact on quality of life and can compromise adherence to chemotherapy ... See full document

... XELOX chemotherapy-induced adverse effect CINV is among the most tor- menting symptoms [20, ...that nausea and emesis following anticancer chemotherapy ...The impact of CINV on patients’ daily ... See full document

... plus 5- hydroxytryptamine type 3 receptor antagonist (5- HT3 RA) compared with 5- HT3 RA plus dexamethasone for the prevention and treatment of chemotherapy- induced ... See full document

... Purpose: Nausea and vomiting are major adverse effects of chemotherapy and can greatly impact patients’ quality of ...Although chemotherapy-induced nausea and vomiting ... See full document

... full 5-day at- risk period in patient populations receiving HEC and MEC specifically for breast, GI/colorectal, and lung cancers, and in populations stratified by age (65 and 65 ...NK-1 receptor ... See full document

... anticipatory nausea (AN; Limebeer et ...a nausea-inducing drug, as the unconditioned stimulus, and a distinctive context as the conditioned ...toxin-induced nausea with the context in which they ... See full document

... When the nabilone treatment cycle was compared with the prochlorperazine treatment cycle in each patient, three patients re- ported complete elimination of nausea, vomiting, and retching[r] ... See full document

... Eligible patients were verbally invited to participate in the study, and written consent was obtained from those who agreed to join. Baseline demographic and disease char- acteristics were collected from patient medical ... See full document

... Uncontrollable nausea and vomiting can cause delay in chemotherapy period and a general decrease in patient’s quality of ...reducing nausea and vomiting, the present study was ... See full document

... enced nausea and vomiting and/or side effects with the use of standard antiemetic agents were submitted in the following cycle of a similar chemotherapy regimen to a compassionate-use program of ... See full document

... after treatment administration and typically resolves within the first 24 ...of nausea include female sex, age < 50 years, environment of administration, lack of history of chronic alcoholism, his- tory ... See full document

... Figure 4 shows the preventive effect of 8 antiemetic regimens on delayed vomiting, with the outcomes of a total of 6,143 patients being reported. CR analysis revealed that netupitant + palonosetron + dexamethasone ... See full document

... ) receptor antagonists have been in development as potential treatments for ...the 5-HT 2A mechanism in sleep, the preclinical and clinical data supporting a role for 5-HT 2A receptor ... See full document